News Opinion Off Script One Big Beautiful Bill Act Doesn’t Spare Cardiology William A. Van Decker, MD August 04, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
Presentation TCT 2024 TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial Presenter: Diaa Hakim October 29, 2024
News Conference News EuroPCR 2021 FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold Michael O'Riordan May 19, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
Presentation TCT 2020 The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention Presenter: Gregg Stone October 14, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Daily News Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events Shelley Wood January 20, 2020
News Conference News VIVA 2019 Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee? L.A. McKeown November 06, 2019
Presentation TCT 2019 Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update Presenter: David Erlinge September 27, 2019
News Conference News HRS 2019 Patients Often Lack Basic Knowledge About Their Implanted Devices Todd Neale May 08, 2019
News Daily News Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI Todd Neale January 04, 2019
News Conference News TCT 2018 Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques Yael L. Maxwell September 24, 2018
Presentation ESC 2018 ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Presenter: Robert Byrne August 29, 2018
News Conference News SCAI 2018 Interventional Appetite Erodes for Dissolving Polymers and Scaffolds Shelley Wood May 04, 2018
News Industry News The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial December 06, 2017
Presentation TCT 2017 Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples) Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn November 01, 2017
Presentation TCT 2017 TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Alberto Barioli, MD October 31, 2017